Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells

Hideyuki Yamawaki1, Kazuaki Saito, Muneyoshi Okada

  • 1Dept. of Veterinary Pharmacology, Kitasato University., Towada, Aomori 034-8628, Japan. yamawaki@vmas.kitasato-u.ac.jp

Insights

Methylglyoxal (MGO), a glucose metabolite elevated in diabetes, causes vascular endothelial cell (EC) damage. MGO triggers inflammatory responses via JNK and p38 pathways, but these pathways do not mediate MGO-induced cell damage.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Vascular Biology

Background:

  • Methylglyoxal (MGO) is a reactive glucose metabolite.
  • Elevated plasma MGO is observed in diabetic patients.
  • MGO is implicated in diabetes-associated vascular endothelial cell (EC) injury and atherosclerosis.

Purpose of the Study:

  • To investigate the effects of MGO treatment on human umbilical vein ECs.
  • To examine MGO's impact on EC morphology and inflammatory responses.

Main Methods:

  • Treatment of human umbilical vein ECs with varying concentrations of MGO (0-420 microM) for different durations (20 min to 24 h).
  • Assessment of EC morphology, cyclooxygenase-2 (COX-2) mRNA and protein expression, PGE(2) release, and MAP kinase (JNK, p38, ERK) and NF-kappaB activation.
  • Utilized JNK and p38 inhibitors (SP600125, SB203580) and a superoxide dismutase/catalase mimetic (EUK134) to elucidate pathways.

Main Results:

  • MGO induced concentration-dependent cytotoxic morphological changes in ECs.
  • MGO upregulated COX-2 expression and PGE(2) release in a concentration- and time-dependent manner.
  • MGO activated JNK and p38 MAP kinases but not ERK or NF-kappaB; JNK and p38 inhibition prevented COX-2 induction, but not morphological damage.

Conclusions:

  • MGO mediates JNK- and p38-dependent inflammatory responses in ECs, potentially independent of oxidative stress.
  • MGO-induced morphological cell damage appears to be independent of the COX-2/PGE(2) pathway.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...